Bot technology can disrupt the pharma industry in many ways. One way is through delivery of content-on-demand based on a patient’s or provider’s interest in learning more about a drug or trial. Another is through intake tools that ascertain the willingness of an individual to participate as a study patient or as an investigator, with straightforward identity authentication (akin to the way e-commerce sites authenticate you by your device ID, Facebook login, or other already vetted validation steps), according to Tim Sayed, MD, MBA

Dr. Sayed’s comments were included in the Trending 2017: Health Bots article.  See more of his insights in the full piece from PharmaVOICE at Health Bots.